The current study aims to examine the immunohistochemical staining of arginase-1 in cases of HCC, metastatic carcinoma involving the liver and cholangiocarcinoma as compared to HepPar-1 that is conventially used. Here, ARG1 is linked to hepatocellular carcinoma.